|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bhatla N, Aoki D, Sharma DN and
Sankaranarayanan R: Cancer of the cervix uteri: 2021 update. Int J
Gynaecol Obstet. 155:28–44. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wright JD, Matsuo K, Huang Y, Tergas AI,
Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI and
Hershman DL: Prognostic performance of the 2018 international
federation of gynecology and obstetrics cervical cancer staging
guidelines. Obstet Gynecol. 134:49–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Diao X, Guo C, Jin Y, Li B, Gao X, Du X,
Chen Z, Jo M, Zeng Y, Ding C, et al: Cancer situation in China: An
analysis based on the global epidemiological data released in 2024.
Cancer Commun (Lond). 45:178–197. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bizzarri N, Querleu D, Dostálek L, van
Lonkhuijzen LRCW, Giannarelli D, Lopez A, Salehi S, Ayhan A, Kim
SH, Ortiz DI, et al: Survival associated with extent of radical
hysterectomy in early-stage cervical cancer: A subanalysis of the
Surveillance in Cervical CANcer (SCCAN) collaborative study. Am J
Obstet Gynecol. 229:428.e1–428.e12. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cibula D, Abu-Rustum NR, Benedetti-Panici
P, Köhler C, Raspagliesi F, Querleu D and Morrow CP: New
classification system of radical hysterectomy: Emphasis on a
three-dimensional anatomic template for parametrial resection.
Gynecol Oncol. 122:264–268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de la Rochefordiere A, Kamal M, Floquet A,
Thomas L, Petrow P, Petit T, Pop M, Fabbro M, Kerr C, Joly F, et
al: PIK3CA pathway mutations predictive of poor response following
standard Radiochemotherapy ± Cetuximab in cervical cancer patients.
Clin Cancer Res. 21:2530–2537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pujade-Lauraine E, Tan DSP, Leary A, Mirza
MR, Enomoto T, Takyar J, Nunes AT, Chagüi JDH, Paskow MJ and Monk
BJ: Comparison of global treatment guidelines for locally advanced
cervical cancer to optimize best care practices: A systematic and
scoping review. Gynecol Oncol. 167:360–372. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Loiselle C and Koh WJ: The emerging use of
IMRT for treatment of cervical cancer. J Natl Compr Canc Netw.
8:1425–1434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang AJ, Richardson S, Grigsby PW and
Schwarz JK: Split-field helical tomotherapy with or without
chemotherapy for definitive treatment of cervical cancer. Int J
Radiat Oncol Biol Phys. 82:263–269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ahamad A, D'Souza W, Salehpour M, Iyer R,
Tucker SL, Jhingran A and Eifel PJ: Intensity-modulated radiation
therapy after hysterectomy: Comparison with conventional treatment
and sensitivity of the normal-tissue-sparing effect to margin size.
Int J Radiat Oncol Biol Phys. 62:1117–1124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang J, Gao J, Zhang F, Gu F, Ding S,
Yang Q, Bai Y and Li G: Pelvic bone marrow sparing intensity
modulated radiation therapy reduces the bone mineral density loss
of patients with cervical cancer. Int J Radiat Oncol Biol Phys.
121:107–117. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu CN, Wang JD, Chen WC, Lin CY, Chiu TJ,
Yang YH, Chang JT, Luo SD and Wang YM: Intensity-modulated proton
therapy versus volumetric-modulated ARC therapy in patients with
nasopharyngeal carcinoma: A long-term, multicenter cohort study.
Radiother Oncol. 202:1106482025. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roy S, MacRae R, Grimes S, Malone J, Lock
M, Mehra P, Morgan SC and Malone S: Helical tomotherapy Versus
3-dimensional conformal radiation therapy in High-risk prostate
cancer: A phase 3 randomized controlled trial. Int J Radiat Oncol
Biol Phys. 120:1386–1393. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Q, Fan S, Xu X, Du S, Zhu G, Jiang
C, Xia SA, Li Q, Wang Q, Qian D, et al: Efficacy and toxicity of
moderately hypofractionated radiation therapy with helical
tomotherapy versus conventional radiation therapy in patients with
unresectable stage III Non-small cell lung cancer receiving
concurrent chemotherapy: A multicenter, randomized phase 3 trial.
Int J Radiat Oncol Biol Phys. 120:422–431. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feliciani G, Licciardello T, Guidi C, Del
Duca M, Mazzotti G, Bellia SR, Ghigi G, Romeo A and Sarnelli A:
Comparison of HDR-brachytherapy and tomotherapy for the treatment
of non-melanoma skin cancers of the head and neck. Radiother Oncol.
204:1107032024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Vulpen M, Field C, Raaijmakers CP,
Parliament MB, Terhaard CH, MacKenzie MA, Scrimger R, Lagendijk JJ
and Fallone BG: Comparing step-and-shoot IMRT with dynamic helical
tomotherapy IMRT plans for head-and-neck cancer. Int J Radiat Oncol
Biol Phys. 62:1535–1539. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bhatla N, Berek JS, Cuello Fredes M, Denny
LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB,
Prat J, et al: Revised FIGO staging for carcinoma of the cervix
uteri. Int J Gynaecol Obstet. 145:129–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sehnal B, Sláma J, Kmoníčková E, Dubová O
and Zikán M: The changes in FIGO staging for carcinoma of the
cervix uteri. Ceska Gynekol. 84:216–221. 2019.PubMed/NCBI
|
|
21
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 6:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Small W Jr, Mell LK, Anderson P,
Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L,
Schefter T, Iyer R, et al: Consensus guidelines for delineation of
clinical target volume for intensity-modulated pelvic radiotherapy
in postoperative treatment of endometrial and cervical cancer. Int
J Radiat Oncol Biol Phys. 71:428–434. 2028. View Article : Google Scholar
|
|
23
|
National Comprehensive Cancer Network
(NCCN), . NCCN clinical practice guidelines in oncology. Cervical
cancer. Version 3. 2024.http://www.nccn.org
|
|
24
|
Cervical Cancer Committee of China
Anti-Cancer Association, . Guidelines for the Treatment of Locally
Advanced Cervical Cancer (2025 edition). Chin J Practical Gynecol
Obstet. 2:186–193. 2025.
|
|
25
|
Ezzell GA, Burmeister JW, Dogan N, LoSasso
TJ, Mechalakos JG, Mihailidis D, Molineu A, Palta JR, Ramsey CR,
Salter BJ, et al: IMRT commissioning: Multiple institution planning
and dosimetry comparisons, a report from AAPM Task Group 119. Med
Phys. 36:5359–5373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klein EE, Hanley J, Bayouth J, Yin FF,
Simon W, Dresser S, Serago C, Aguirre F, Ma L, Arjomandy B, et al:
Task Group 142 report: Quality assurance of medical accelerators.
Med Phys. 36:4197–212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ko CC, Yeh LR, Kuo YT and Chen JH: Imaging
biomarkers for evaluating tumor response: RECIST and beyond.
Biomark Res. 9:522021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cox JD, Stetz J and Pajak TF: Toxicity
criteria of the radiation therapy oncology Group (RTOG) and the
european organization for research and treatment of cancer (EORTC).
Int J Radiat Oncol Biol Phys. 31:1341–1346. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang X, Wang T, Xiao X, Li X, Wang CY,
Huang B, He L and Song Y: Radiotherapy for head and neck tumours
using an oral fixation and parameter acquisition device and TOMO
technology: A randomised controlled study. BMJ Open.
11:e0525422021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Keiler L, Dobbins D, Kulasekere R and
Einstein D: Tomotherapy for prostate adenocarcinoma: A report on
acute toxicity. Radiother Oncol. 84:171–176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sheng K, Molloy JA and Read PW:
Intensity-modulated radiation therapy (IMRT) dosimetry of the head
and neck: A comparison of treatment plans using linear
accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol
Biol Phys. 65:917–923. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee TF, Fang FM, Chao PJ, Su TJ, Wang LK
and Leung SW: Dosimetric comparisons of helical tomotherapy and
step-and-shoot intensity-modulated radiotherapy in nasopharyngeal
carcinoma. Radiother Oncol. 89:89–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsieh CH, Wei MC, Lee HY, Hsiao SM, Chen
CA, Wang LY, Hsieh YP, Tsai TH, Chen YJ and Shueng PW: Whole pelvic
helical tomotherapy for locally advanced cervical cancer: Technical
implementation of IMRT with helical tomotherapy. Radiat Oncol.
4:622009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang R, Xu S, Jiang W, Xie C and Wang J:
Integral dose in three-dimensional conformal radiotherapy,
intensity-modulated radiotherapy and helical tomotherapy. Clin
Oncol (R Coll Radiol). 21:706–712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shang H, Pu Y, Wang W, Dai Z and Jin F:
Evaluation of plan quality and robustness of IMPT and helical IMRT
for cervical cancer. Radiat Oncol. 15:342020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cheng YK, Kuo SH, Yen HH, Wu JH, Chen YC
and Huang MY: The prognostic significance of pretreatment squamous
cell carcinoma antigen levels in cervical cancer patients treated
by concurrent chemoradiation therapy and a comparison of dosimetric
outcomes and clinical toxicities between tomotherapy and volumetric
modulated arc therapy. Radiat Oncol. 17:912022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Chen Z, Zhou Q, Shang X, Zhao W,
Zhang G and Xu S: A feasibility study of dose-band prediction in
radiation therapy: Predicting a spectrum of plan dose. Radiother
Oncol. 202:1105932025. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fu Q, Chen X, Liu Y, Zhang J, Xu Y, Yang
X, Huang M, Men K and Dai J: Improvement of accumulated dose
distribution in combined cervical cancer radiotherapy with deep
learning-based dose prediction. Front Oncol. 14:14070162024.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu M, Jang HS, Jeon DM, Cheon GS, Lee HC,
Chung MJ, Kim SH and Lee JH: Dosimetric evaluation of Tomotherapy
and four-box field conformal radiotherapy in locally advanced
rectal cancer. Radiat Oncol J. 31:252–259. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cihoric N, Tsikkinis A, Tapia C, Aebersold
DM, Zlobec I and Lössl K: Dose escalated intensity modulated
radiotherapy in the treatment of cervical cancer. Radiat Oncol.
10:2402015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Engels B, De Ridder M, Tournel K, Sermeus
A, De Coninck P, Verellen D and Storme GA: Preoperative helical
tomotherapy and megavoltage computed tomography for rectal cancer:
Impact on the irradiated volume of small bowel. Int J Radiat Oncol
Biol Phys. 74:1476–1480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Marnitz S, Lukarski D, Köhler C,
Wlodarczyk W, Ebert A, Budach V, Schneider A and Stromberger C:
Helical tomotherapy versus conventional intensity-modulated
radiation therapy for primary chemoradiation in cervical cancer
patients: An intraindividual comparison. Int J Radiat Oncol Biol
Phys. 81:424–430. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu J, Tang G, Zhou Q and Kuang W:
Outcomes and prognostic factors in patients with locally advanced
cervical cancer treated with concurrent chemoradiotherapy. Radiat
Oncol. 17:1422022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gao X, Kong Y, Ning Y, Tian T, Gai X, Lei
K and Cui Z: The prognosis of patients with locally advanced
cervical cancer undergoing surgical versus non-surgical treatment:
A retrospective cohort study based on SEER database and a
single-center data. Int J Surg. 1:1619–1623. 2025. View Article : Google Scholar
|
|
45
|
Li D, Wang D, Feng S, Chen Q, Sheng X, Jia
J, Yan X, Zhu J and Yin Y: Comparing dosimetric and cancer control
outcomes after intensity-modulated radiation therapy and
tomotherapy for advanced cervical cancer. Oncol Lett. 24:2392022.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Renard-Oldrini S, Guinement L, Salleron J,
Brunaud C, Huger S, Grandgirard N, Villani N, Marchesi V, Oldrini G
and Peiffert D: Dosimetric comparaison between VMAT and tomotherapy
with Para-aortic irradiation for cervix carcinoma. Cancer
Radiother. 19:733–738. 2015.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yeung R, McConnell Y, Warkentin H, Graham
D, Warkentin B, Joseph K and Doll CM: Intensity-modulated
radiotherapy (IMRT) vs helical tomotherapy (HT) in concurrent
chemoradiotherapy (CRT) for patients with anal canal carcinoma
(ACC): An analysis of dose distribution and toxicities. Radiat
Oncol. 10:922015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lapierre A, Bourillon L, Larroque M,
Gouveia T, Bourgier C, Ozsahin M, Pèlegrin A, Azria D and Brengues
M: Improving patients' life quality after radiotherapy treatment by
predicting late toxicities. Cancers (Basel). 14:20972022.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dijkstra EA, Hospers GAP, Kranenbarg EM,
Fleer J, Roodvoets AGH, Bahadoer RR, Guren MG, Tjalma JJJ, Putter
H, Crolla RMPH, et al: Quality of life and late toxicity after
short-course radiotherapy followed by chemotherapy or
chemoradiotherapy for locally advanced rectal cancer-The RAPIDO
trial. Radiother Oncol. 171:69–76. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Greimel ER, Kuljanic Vlasic K, Waldenstrom
AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic
V and Wydra D: European Organization for Research and Treatment of
Cancer Quality-of-Life Group: European organization for research
and treatment of cancer Quality-of-Life Group: The european
organization for research and treatment of cancer (EORTC)
Quality-of-Life questionnaire cervical cancer module: EORTC
QLQ-CX24. Cancer. 107:1812–1822. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ding Y, Hu Y and Hallberg IR: Psychometric
properties of the Chinese version of the Functional Assessment of
Cancer Therapy-Cervix (FACT-Cx) measuring health-related quality of
life. Health Qual Life Outcomes. 10:1242012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schörghofer A, Groher M, Karner J, Kopp A,
Kametriser G, Kunit T, Holzinger J, Sedlmayer F and Wolf F:
Risk-adapted moderate hypofractionation of prostate cancer: A
prospective analysis of acute toxicity, QOL and outcome in 221
patients. Strahlenther Onkol. 10:894–901. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Fransson P, Nilsson P, Gunnlaugsson A,
Beckman L, Tavelin B, Norman D, Thellenberg-Karlsson C, Hoyer M,
Lagerlund M, Kindblom J, et al: Ultra-hypofractionated versus
conventionally fractionated radiotherapy for prostate cancer
(HYPO-RT-PC): Patient-reported quality-of-life outcomes of a
randomised, controlled, Non-inferiority, phase 3 trial. Lancet
Oncol. 22:235–245. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Schuurhuizen CSEW, Braamse AMJ, Konings
IRHM, Sprangers MAG, Ket JCF, Dekker J and Verheul HMW: Does severe
toxicity affect global quality of life in patients with metastatic
colorectal cancer during palliative systemic treatment? A
systematic review. Ann Oncol. 28:478–486. 2017. View Article : Google Scholar : PubMed/NCBI
|
